WHO gives nod to use of Malaria vaccine on children in Africa

The World Health Organisation has given a go-ahead for the use of Mosquirix the only approved anti-malaria vaccine, to prevent children in Africa from getting affected by the disease. Mosquirix has been developed by British drugmaker GlaxoSmithKline. "Using this vaccine in addition to existing tools to prevent malaria could save tens of thousands of young lives each year," WHO chief Tedros Adhanom Ghebreyesus said.